Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
FDA approves Tarceva (erlotinib)

FDA approves Tarceva (erlotinib)

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

Radiation either before or after chemotherapy and surgery just as effective for treating lung cancer

Radiation either before or after chemotherapy and surgery just as effective for treating lung cancer

Biomira and Merck announce fast track status for liposome vaccine

Biomira and Merck announce fast track status for liposome vaccine

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

New Drug Application with the U.S. Food and Drug Administration for Tarceva

New Drug Application with the U.S. Food and Drug Administration for Tarceva

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Cognitive decline can occur before chemotherapy treatment

Cognitive decline can occur before chemotherapy treatment

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Drug Tarceva improves survival chance for patients with advanced lung cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Combination of real-time PET and CT is a highly sensitive tool for identifying non-small cell lung cancer

Combination of real-time PET and CT is a highly sensitive tool for identifying non-small cell lung cancer

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

Lung tumor therapies improved by combining scanning technologies

Lung tumor therapies improved by combining scanning technologies